Subscribe To Our Free Newsletter |
Strides Pharma’s subsidiary gets USFDA approved, shares up
The shares were up by 0.67 per cent to ₹489.70 at 10 am on the BSE
Subscribe To Our Free Newsletter |
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Latest Stock Market News
The Most Valuable Commodity Is Information!